Heading to dream of how many lives Leronlimab can

Quote:

---

This Form 144 filing is in fact very real. What it indicates is that CytoDyn CEO Dr. Pourhassan exercised 11 years of options cashlessly, which resulted in a sale of shares (as in, past tense) on April 30, of 4,821,174 shares at an approximate price of $3.25. It doesn’t mean Pourhassan is filing to sell—it means this is a done deal, period. It’s in the history books and there is NO OVERHANG from this transaction. So the next question is: WHY WOULD HE DO THIS!? The shorts would have to believe that all insider selling is bad, but the reality is that insiders sell for a variety of reasons and it’s a mixed bag when it comes to figuring out their motives. However, in this case, it’s very transparent. No one on the planet would be so stupid to sell right before a major announcement, giving up a tremendous amount of potential profit unless they literally had a gun to their head. In the next section you will learn that there was in fact a proverbial gun to CytoDyn’s head, motivated by greed, and Dr. Pouhassan wasn’t going to sit back and watch people die. If Dr. Pourhassan is guilty of anything he is going to be convicted of saving tens of thousands of lives for his heroic actions in a time of governmental inaction.

---